Lululemon Athletica Inc vs 22nd Century Group Inc — how do they compare? Lululemon Athletica Inc trades at $94.5 (market cap $10.27B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Lululemon Athletica Inc is far larger — about 16520× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 4,392,324). Which is the better fit depends on your goals — on Pluang, investors hold Lululemon Athletica Inc for 105 Days and 22nd Century Group Inc for 32 Days on average.
| LULU | XXII | |
|---|---|---|
Market Cap | $10.27B | $621.67K |
Volume | 4,392,324 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $215.88 | $483.00 |
52-Week Low | $91.88 | $0.80 |
Typical Hold Time | 105 Days | 32 Days |
Enterprise Value | $11.02B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Lululemon stock trades at $94.5, down 54% year-to-date and near its 52-week low, reflecting a bearish technical trend. Despite strong profitability with a 12.78% net income margin and a low P/E of 7.63, the stock faces headwinds from recent revenue declines and multiple securities fraud investigations. Earnings have beaten estimates in recent quarters, but negative sentiment and governance concerns weigh on investor confidence.
The outlook remains cautious; the stock's deep discount to historical valuations presents a potential opportunity, but risks from legal probes, competitive pressures, and weak growth visibility suggest limited near-term upside. Analyst consensus is mixed with a $97.67 price target, indicating modest potential from current levels amid high uncertainty.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →